Perhaps because the majority of BRCA2-associated breast tumors are estrogen receptor (ER)-positive, as are the majority of non-hereditary breast cancers [26], risk alleles for sporadic breast cancer are more likely to be modifiers of risk of BRCA2-associated hereditary breast cancer. This evidence concerns the gene ESR1 and breast neoplasm.